Joint report of the Third International Workshop on Canine Immunogenetics. I. Analysis of homozygous typing cells. 1986

H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein

The Third International Workshop on Canine Immunogenetics involved 80 potentially DLA-D homozygous typing cells obtained from dogs of various breeds and submitted from five laboratories in Europe and the United States. Mutual reactivity of all cells was studied in mixed leukocyte cultures, and stabilized relative responses were used for analysis. Intralaboratory and interlaboratory comparisons of results suggest that a stabilized relative response of 30% represents an acceptable parameter for "typing responses" indicating phenotypic DLA-D identity of stimulator and responder cells. Using this criterion, 10 clusters of homozygous typing cells were defined and accepted on an international level, and they were assigned the specificities Dw1 to Dw10. At least six additional (provisional) specificities were recognized that were well characterized within individual laboratories but require additional testing before workshop specificities can be assigned. These data show that DLA-D typing is feasible and represents a useful tool in the genetic analysis of the canine major histocompatibility complex. Much work is needed to confirm the present results in family studies, to determine gene frequencies, and to analyze at a molecular level the antigens responsible for mixed leukocyte culture reactivity.

UI MeSH Term Description Entries
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008285 Major Histocompatibility Complex The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Complex,Complex, Histocompatibility,Complex, Major Histocompatibility,Complices, Histocompatibility,Complices, Major Histocompatibility,Histocompatibility Complex, Major,Histocompatibility Complices,Histocompatibility Complices, Major,Major Histocompatibility Complices
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
January 1987, Transplantation,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
January 1973, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
June 1976, Transplantation proceedings,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
April 2007, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
April 2007, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
April 2007, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
April 2007, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
April 2007, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
March 2011, Tissue antigens,
H J Deeg, and R F Raff, and H Grosse-Wilde, and A M Bijma, and W A Buurman, and I Doxiadis, and H J Kolb, and K Krumbacher, and W Ladiges, and K L Losslein
March 2005, Clinical lymphoma,
Copied contents to your clipboard!